الأحد، 25 نوفمبر 2012

الروماتويد اسبابه اعراضه علاجه والتخلص منه

ما هو الروماتويد

الاسباب التى تئدى الى الإصابة بمرض الروماتويد

علامات الاصابة بمرض الروماتويد

أعراض الاصابة بمرض الروماتويد

التخلص من مرض الروماتويد

كيفية علاج مرض الروماتويد

 

 

 

أولا التعرف على مرض الروماتويد

الروماتويد من الامراض المزمنة التى تصيب الجسم بسبب اضطراب جهاز المناعة يعمل مرض الروماتويد على  تاّكل انسجة المحيطة بالمفاصل خاصة المفاصل الصغيرة كمفاصل الرسغين ومفاصل اليدين والعضلات وأغلفة الاعصاب  مما يؤدى الى تّكل تلك المفاصل وتشوهها

كما ذكرنا أن مرض الروماتويد مرض مزمن يبقى مع المصاب مدى الحياة

مع ذلك يوجد بعض الحالات التى يمكن أن تتحسن لفترة مع إمكانية عودة المرض مرة أخرى

ويتميز هذا المرض بتطوره فهو يزداد مع الوقت الا أنه فى بعض الاوقات قد يكون خفيفاً

 

 

ما هى اسباب الاصابة بمرض الروماتويد

 

لا يوجد سبب محدد لٌلإصابة بمرض الروماتويد فقد يكون السبب

علاقة جينية وراثية  قد يصيب عائلات بعينها قد تصاب بتلك المرض

عدوى بكتيرية

غدد هرمونية

اسباب حساسية الاعراض التى تصاحب مرض الروماتويد قد تشبة الى حد كبير أعراض الحساسية أسباب تعود الى الاختلال الميتابوليزم

 

 

علامات الاصابة بمرض الروماتويد

 

يظهر مرض الروماتويد قى الإناث أكثر من الذكور

يشعر المريض بإرتفاع درجة الحرارة مصاحبة بنوبات روماتزمية تؤدى تدريجيا الى تيبس وإلتهاب المفاصل مع انحراف فى مسار اليدين مع خلع فى مفاصل اليد تؤدى الى فقدان حركة المفاصل

وجود بثور على جلد الساقين

حدوث ألاّم عند حركة المفاصل مع تورمها

تييبس

 

كيفية التأكد من الإصابة بمرض الروماتويد

 

عن طريق عمل أشعة سينية التى تظهر اذا ما كان هناك تاّكل فى المفاصل او تشوهها

كما يمكن أكتشاف مرض الروماتويد من خلال فحص الدم ووجود ترسب الدم ESR ووجود عامل الروماتويد  ووجود سى –ر-بروتين CRP

 

                                                                                                                 علاج مرض الروماتويد

مدونة الصيدلية: Ways of treating vitiligo in childhood

مدونة الصيدلية: Ways of treating vitiligo in childhood: What are the treatment methods that can be used in childhood ?   Treating vitiligo depends on the type of vitiligo and ...

الأحد، 18 نوفمبر 2012

Ways of treating vitiligo in childhood

What are the treatment methods that can be used in childhood?
 
Treating vitiligo depends on the type of vitiligo and the age of the patient ... In cases of vitilig
 
children Naroband and Albrootopk (cream immune inhibitor) have achieved better therapeutic results
 
50% of patients begins with the appearance of vitiligo have before the age of twenty years.

There are many ways to treat, including:



_ Topical corticosteroids

Topical steroids are often the first choice for the treatment of vitiligo.
 
_ Topical immunomodulators:
With a topical immunomodulators such as (ointment Albrootopk cream Aledel), put many hope to be a cure for a number of skin problems including vitiligo.

There are a number of studies have shown the effectiveness of these treatments, which are close to effective topical Alstaruyat without the attendant side effects caused by steroids.

Since it is safe for long-term treatment, the topical immunomodulators drugs might be better used to treat small areas of vitiligo or in difficult locations such as the eyelids.
 
 
_ Naroband:

Narrow beams of ultraviolet (b) has emerged recently as a treatment for vitiligo rampant in children.

Analysis study in 1999 and found that Naroband is the most effective and safe for the treatment of vitiligo in children.



Later a number of children have been treated in this way and the best results on vitiligo existing face and neck and vitiligo modern history.
The vitiligo of the hands and feet were weak response.
 
_ Surgical treatments:
Surgical methods are other options in the treatment of vitiligo.

Cultivation of pigment cells from the same patient and sedentary in small places
 
 
Cosmetic creams hide the flaws:
If all treatments fail, the patient usually does not want to receive treatment, so the use of cosmetics and cover defects can be very useful.
 
_ Bleach:
Must focus here that this method does not allow for children.
 
 
 

Photo vitiligo in children

Hair can be also vulnerable to injury vitiligo
And may be associated with various other spots of the body
Body hair may change to white due to the development of vitiligo.
 
Vitiligo is hyperbolic nonsegmental
Spots bilateral and symmetrical
It is the most common
This type of vitiligo spots that are scattered in a symmetrical manner
Note in the picture (2) that vitiligo symmetrically in the eyes
The presence of spots on the side of symmetrically in the same the other side
And characterized by increasing in size and number of spots with the passage of time
This type appears to be at any age

These other forms of vitiligo is hyperbolic .. Metastatic
 
 
Limited or vitiligo
Characterized as non-symmetrical
But in a limited area of the body
And where are the white patches
Confined to one area of the body and on the path of a particular nerve,
The prevalence 72-95%
Beginning of his appearance at an early age

الجمعة، 2 نوفمبر 2012

DECLOPHEN


DECLOPHEN Infantile Suppositories

12.5 & 25 MG 

 

Company name : Pharco Pharmaceuticals

Trade name : Declophen Infantile Suppositories 12.5 & 25 mg

 Generic name : Diclofenac Sodium

 COMPOSITION : Each suppository contains

 Diclofenac sodium 12.5 or 25 mg

 Pharmaceuticals form : Suppositories

PHARMACOLOGICAL ACTION:

Declophen is a non-steroidal anti-rheumatic, anti-inflammatory, analgesic and antipyretic properties. Diclofenac sodium, the active ingredient in declophen suppositories, has a potent inhibitory effect on the cyclo-oxygenase pathway of prostaglandin synthesis. This causes a remarkable decrease in the amount of prostaglandins and, in turn, the response to pain and inflammatory reactions or injurious agents is abolished.

 

PHARMACOKINETICS :

 Diclofenac shows a rapid onset of absorption from suppositories. The amount absorbed in linearly related to the size of the dose. Pharmacokinefic behaviour does not change after repeated administration. No accumulation occurs provided the recommended intervals are observed. The plasma concentrations attained in children given equivalent doses (mg/kg body weight) are similar to those obtained in adults.

 

 INDICATIONS:

 Juvenile rheumatoid arthritis. Post-traumatic and postoperative pain, inflammation, and swelling e.g. following orthopaedic surgery. As an adjuvant in severe painful inflammatory infections of the ear, nose. or throat, e.g. pharyngotonsillitis, otitis. In keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. Fever alone is not an indication.

 

 DOSAGE:

 Children aged (1 - 12 years): 1 -3 mg/kg per day in divided doses (12.5 mg and 25 mg suppositories only). Children (aged 6-12  years) with acute post-operative pain 1 - 2 mg/kg per day in divided doses. Treatment of acute post-operative pain should be limited to 4 days treatment (12.5 mg and 25 mg suppositories only)

 

. CONTRAINDICATIONS:

 Gastric or intestinal ulcer. Known hypersensitivity to Diclofenac sodium. Like other non-steroidal anti-inflammatory drugs, Declophen is contraindicated in patients in whom attacks of asthma, or acute rhinitis by acetylsalicylic acid or other drugs with prostaglandins-synthetase

inhibiting activity. It is also contraindicated in proctitis.

 

SIDE EFFECTS:

Mild and infrequent gastro-intestinal disturbances (epigastric pain. nausea ), skin rash, pruritus, headache or oedema might occur in some patients.

 

DRUG INTERACTIONS:

 Lithium & digoxin: Declophen may increase plasma concentrations of lithium & digoxin.

 Anticoagulants : Close monitoring of patients is required when receiving concomitant anticoagulants and Declophen.

Cyclosporins

Cases of nephrotoxicity have been reported in patients receiving concomitant cyclosporin and Declophen.

 Methotrexate

 Cases of serious toxicity have been reported when methotrexate and NSAIDS are given within 24 hours of each other.

 

 Quinolone antimicrobials

Caution should be exercised when considering the use of quinolone in patients who are already receiving an NSA ID.

 

 Antidiabetics

Clinical studies have shown that Declophen can be given together with oral antidiabetic agents without influencing their clinical effect. However, there have been isolated reports of both hypoglycaemic and hyperglycaemic effects which have required adjustment to the dosage of hypoglycaemic agents.

 

 Diuretics

Concomitant treatment with potassium-sparing diuretics may be associated with increased serum potassium levels, which should therefore be monitored frequently.

 

Mifepristone

NSAIDS should not be used for 8 - 12 days after mifepristone administration.

 

WARNINGS & PRECAUTIONS:

Use under close medical supervision in case of gastro-intestinal disorders with a history of gastric or intestinal ulceration, with ulcerative colitis or with Crohn's disease and in severe impairment of hepatic function. Like other NSAIDS, Declophen may mask the signs and symptoms of infection. Avoid concomitant use of two or more NSAIDS. PACKING: A box containing 5 suppositories. STORAGE: Keep at temperature less than 5° C Keep all medicines out of the reach of children